Magnetoencephalography (MEG): Improving Patient Care Through Advanced Non-Invasive Brain Mapping
From preserving brain function and reducing reliance on invasive procedures, magnetoencephalography (MEG) expands what’s possible in neurological care.
Neuroscience News
-
-
Improving Care of Patients with Down Syndrome: The Clinical Impact of an Integrated Lifespan Model
What happens when care for pediatric and adult patients with Down syndrome is connected in one place?
-
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
-
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was... -
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
-
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
-
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
-
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
With an aging population and increases in the prevalence of neurological conditions like Alzheimer’s disease and dementia, physicians and patients alike continue to seek new tools and approaches to...
-
Accelerating Identification and Treatment of Infectious Diseases Through On-site Next-Generation Sequencing
Mortality rates from treatment-resistant pathogens continue to rise, and the culprits include a wide and growing range of mycobacteria and fungi.
As a former clinically practicing physician who now...
-
Recent Study on How Physical Activity May Boost Neurocognition in Late Adulthood Featured in the Medical Journal Age and Ageing
In a new article published in the medical journal Age and Ageing, AdventHealth Research Institute’s Dr. Audrey Collins shares the results of a recent study evaluating the impact of exercise on...
-
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
-
Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases
Breakthrough device offers new hope for stroke survivors struggling with rehabilitation following ischemic stroke
-
AdventHealth Physicians Examine the New Alzheimer’s Infusion Therapies
AdventHealth’s Valeria Baldivieso Hurtado, MD, medical director of memory care at AdventHealth Central Florida, and Daniel Ebele Okobi, Jr., MD, PhD, medical director of behavioral neurology at...
